Literature DB >> 24391424

Sacral nerve stimulation for fecal incontinence. First successful case in Greece.

C Spanos1, Th Mikos2, C Constantogiannis3, G Georgantis1, D Kiskinis1.   

Abstract

INTRODUCTION: Sacral nerve modulation (SNM) is an established and successful treatment for fecal incontinence. We present the first successful case in Greece, performed in our department. PATIENTS AND METHODS: A 60-year-old female patient presented with a 5-year-old history of fecal incontinence. The Cleveland Clinic Florida (CCF) Incontinence Score was 15. Endoanal ultrasound did not show defects of the internal or external anal sphincter. Conservative and pharmacological therapy was unsuccessful. The patient subsequently underwent a total pelvic floor repair, which was also unsuccessful. After discussing further options, the patient gave consent for percutaneous nerve evaluation (PNE), for possible permanent stimulator implantation.
RESULTS: A quadripolar lead was placed percutaneously through the dorsal S3 foramen under local anesthesia. This was connected to a test stimulator (Medtronic Interstim Model 3625, Minneapolis, MN). The stimulator was activated for a period of 4 weeks. At the end of the test period, the CCF Incontinence score was 5. This was considered successful. A permanent stimulator (Medtronic Interstim Implantable Pulse Generator Model 3058, Minneapolis, MN) was then implanted under local anesthesia. Two months after permanent implantation, the Wexner Score has not increased.
CONCLUSION: SNM is a relatively simple, safe and minimally invasive technique for the treatment of fecal incontinence.

Entities:  

Keywords:  fecal incontinence; sacral nerve stimulation

Year:  2011        PMID: 24391424      PMCID: PMC3876858     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  14 in total

Review 1.  Clinical practice. Fecal incontinence in adults.

Authors:  Arnold Wald
Journal:  N Engl J Med       Date:  2007-04-19       Impact factor: 91.245

Review 2.  Investigating and treating fecal incontinence: when and how.

Authors:  Adriana Lazarescu; Geoffrey K Turnbull; Stephen Vanner
Journal:  Can J Gastroenterol       Date:  2009-04       Impact factor: 3.522

3.  Sacral nerve stimulation for faecal incontinence: long-term outcome.

Authors:  K E Matzel; P Lux; S Heuer; M Besendörfer; W Zhang
Journal:  Colorectal Dis       Date:  2008-08-21       Impact factor: 3.788

4.  Electrical stimulation of sacral spinal nerves for treatment of faecal incontinence.

Authors:  K E Matzel; U Stadelmaier; M Hohenfellner; F P Gall
Journal:  Lancet       Date:  1995-10-28       Impact factor: 79.321

Review 5.  Etiology and management of fecal incontinence.

Authors:  J M Jorge; S D Wexner
Journal:  Dis Colon Rectum       Date:  1993-01       Impact factor: 4.585

6.  Predictive factors for successful sacral nerve stimulation in the treatment of faecal incontinence: results of trial stimulation in 200 patients.

Authors:  S Gallas; F Michot; J L Faucheron; G Meurette; P A Lehur; X Barth; H Damon; F Mion; E Rullier; F Zerbib; I Sielezneff; M Ouaïssi; P Orsoni; V Desfourneaux; L Siproudhis; M Mathonnet; J F Menard; A M Leroi
Journal:  Colorectal Dis       Date:  2010-03-10       Impact factor: 3.788

Review 7.  Sacral nerve stimulation for fecal incontinence. What has been achieved (current status).

Authors:  K E Matzel
Journal:  Acta Chir Iugosl       Date:  2010

8.  Predictors of the outcome of percutaneous nerve evaluation for faecal incontinence.

Authors:  Y Maeda; C Norton; L Lundby; S Buntzen; S Laurberg
Journal:  Br J Surg       Date:  2010-07       Impact factor: 6.939

9.  Sacral nerve stimulation is more effective than optimal medical therapy for severe fecal incontinence: a randomized, controlled study.

Authors:  Joe J Tjandra; Miranda K Y Chan; Chung Hung Yeh; Carolyn Murray-Green
Journal:  Dis Colon Rectum       Date:  2008-02-16       Impact factor: 4.585

10.  Sacral nerve stimulation for neurogenic faecal incontinence.

Authors:  B Holzer; H R Rosen; G Novi; C Ausch; N Hölbling; R Schiessel
Journal:  Br J Surg       Date:  2007-06       Impact factor: 6.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.